🇺🇸 FDA
Patent

US 9675615

2,3-dihydroquinazolin-4(1H)-one derivatives for use in the treatment of viral infections

granted A61KA61K31/517A61P

Quick answer

US patent 9675615 (2,3-dihydroquinazolin-4(1H)-one derivatives for use in the treatment of viral infections) held by The Board of Regents of the University of Texas System expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/517, A61P, A61P31/12